ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

RFPS, RFAs Available

September 23, 1994

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992